DOCSLIB.ORG

0 Cover Part Two\374

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
0 Cover Part Two\374 PART TWO DEUXIÈME PARTIE SEGUNDA PARTE ﺍﳉﺰﺀ ﺍﻟﺜﺎﱐ 第二部分 ЧАСТЬ ВТΟΡАЯ - (...), [...] - (-)-3-hidroxi-N- (-)-(2R)-N-méthyl-1- fenacilmorfinán → Levophenacyl-morphan phénylpropan-2-amine → Levometamfetamine (-)-3-hidroxi-N- (-)-(3S,6R)-6- metilmorfinán → Levorphanol (dimethylamino)-4,4- (-)-3-hydroksymorfinan → Norlevorphanol diphenyl-3-heptanol → Betamethadol (-)-3-hydroksy-N- (-)-(3S,6R)-6- fenacylmorfinan → Levophenacyl-morphan (dimethylamino)-4,4- (-)-3-hydroksy-N- diphenyl-3-heptanol metylmorfinan → Levorphanol acetate (ester) → Betacetylmethadol (-)-3-hydroxymorphinan → Norlevorphanol (-)-(5R)-4,5-epoxy-3- (-)-3-hydroxy-N- methoxy-9α-methyl methylmorphinan → Levorphanol → Thebacon morphin-6-en-6-yl acetate (-)-3-hydroxynormorphinan → Norlevorphanol (-)-(5R,6S)-3-benzyloxy-4,5- (-)-3-hydroxy-N- epoxy-9a-methylmorphin- phenacylmorphinan → Levophenacyl-morphan 7-en-6-yl myristate → Myrophine (-)-3-hydroxytropane-2- (-)-(5R,6S)-4,5-epoxy carboxylat → Ecgonine morphin-7-en-3,6-diol → Normorphine (-)-3-idrossi-N- (-)-(5R,6S,14S)-4,5-epoxy- metilmorfinano → Levorphanol 14-hydroxy-3-methoxy- (-)-3-methoxy-N- 9a-methylmorphinan-6- methylmorphinan → Levomethorphan one → Oxycodone (-)-3-metil-2,2-difenil-4- (-)-(R)-4,5-epoxy-3- morfolinbutirilpirrolidina → Levomoramide methoxy-9a-methyl (-)-3-metoksy-N- morphinan-6-one → Hydrocodone metylmorfinan → Levomethorphan (-)-(R)-6-(dimethylamino)- (-)-3-metossi-N-metil- 4,4-diphenyl-3-heptanone → l-methadone morfinano → Levomethorphan (-)-(R)-N,α-dimethyl (-)-3-metoxi-N- phenethylamine → Levometamfetamine metilmorfinán → Levomethorphan (-)-(R)-N,α-dimetil (-)-3-morphinanol fenetilamina → Levometamfetamine → Norlevorphanol (-)-(R)-α-methyl (-)-3-oxy-N-methyl phenethylamine → Levamfetamine morphinan → Levorphanol (-)-(R)-α-méthyl (-)-3β-benzoyloxy-2β- phénéthylamine → Levamfetamine methoxycarbonyltropan → Cocaine (-)-(R)-α-metilfenetilamina → Levamfetamine (-)-3β-benzoyloxytropan-2β- carbonsäuremethylester → Cocaine (-)-(S)-2-aminopropiofenona → Cathinone (-)-4-(2-methyl-4-oxo-3,3- (-)-(S)-2-amino diphenyl-4-pyrrolidin-1- → propiophenone Cathinone ylbutyl)morpholine → Levomoramide (-)-[méthyl-2 oxo-4 (-)-4,5α-epoxy-14-hydroxy- diphényl-3,3 (pyrrolidinyl- 3-methoxy-17- → 1)-4 butyl]-4 morpholine Levomoramide methylmorphinan-6-one → Oxycodone (-)-1-(3-methyl-4- (-)-4-[2-methyl-4-oxo-3,3- morpholino-2,2- diphenyl-4-(1- diphenylbutyryl) pyrrolidinyl)butyl] → pyrrolidin, -e Levomoramide morpholine → Levomoramide (-)-1-(β-methyl-γ- (-)-4-[2-metil-4-oxo-3,3- morpholino-α,α- difenil-4-(l-pirrolidinil) diphenylbutyryl) butil]morfolina → Levomoramide → pyrrolidine Levomoramide (-)-4-[2-metyl-4-okso-3,3- (-)-1,3,4,9,10,10a- difenyl-4-(1-pyrrolidinyl) hexahydro-11-phenethyl- butyl]morfolin → Levomoramide 2H-10,4a-iminoethano (-)-4-morpholino-3-methyl- → phenanthren-6-ol Phenomorphan 2,2-diphenylbutyryl (-)-1-[3-methyl-4-(4- pyrrolidin → Levomoramide morpholinyl)-1-oxo-2,2- (-)-6-(dimethylamino)-4,4- → diphenylbutyl]pyrrolidin Levomoramide diphenyl-3-heptanone → l-methadone (-)-14-hydroxydihydro (-)-6-(dimetilamino)-4,4- → codeinone Oxycodone difenil-3-heptanona → l-methadone (-)-17-methylmorphinan-3-ol → Levorphanol (-)-alfa-aminopropiofenona → Cathinone (-)-1-dimethylamino-1,2- (-)-alpha-aminopropio → diphenylethane Lefetamine phenone → Cathinone (-)-1-dimetilamino-1,2- (-)-alpha-aminopropio → difeniletano Lefetamine phénone → Cathinone (-)-2-[methylamino]-1- (-)-alpha-methyl- → phenylpropane Levometamfetamine phenäthylamin → Levamfetamine (-)-3-hidroximorfinán → Norlevorphanol 315 (-)-alpha-methyl (+)-(3R,6R)-6-(dimethyl phenethylamine → Levamfetamine amino)-4,4-diphenyl-3- (-)-amino-2 phényl-1 propane → Levamfetamine heptanol → Alphacetylmethadol (-)-amino-2 propiophénone- (+)-(3R,6R)-6-dimethyl (S) → Cathinone amino-4,4-diphenyl-3- → (-)-amphetamine → Levamfetamine heptanol Alphamethadol (+)-(R)-α-[(R)-1-aminoethyl] (-)-deoxyephedrine → Levometamfetamine benzyl alcohol → Cathine (-)-diméthylamino-1 (+)-(S)-alfa-[(S)-1- → Lefetamine diphényl-1,2 éthane aminoetil]alcohol (-)-diméthylamino-6 bencílico → Cathine → l-methadone diphényl-4,4 heptanone-3 (+)-(S)-alpha-[(S)-1- (-)-diméthyl-N,α- aminoethyl]benzyl alcohol → Cathine → Levometamfetamine phénéthylamine (+)-(S)-alpha-[(S)-1-amino (-)-hydroxy-3 morphinane → Norlevorphanol éthyl-1] alcool benzylique → Cathine (-)-hydroxy-3 N- (+)-(S)-N,α-dimethyl méthylmorphinane → Levorphanol phenethylamine → Metamfetamine (-)-hydroxy-3 N- (+)-(S)-N,α-diméthyl phénacylmorphinane → Levophenacyl-morphan phénéthylamine → Metamfetamine (-)-methamphetamine → Levometamfetamine (+)-(S)-N,α-dimetil (-)-méthoxy-3 N- fenetilamina → Metamfetamine méthylmorphinane → Levomethorphan (+)-(S)-α-[(S)-1-aminoethyl] (-)-methylphenethylamine benzyl alcohol → Cathine succinate (1:1) → Levamfetamine succinate (+)-(S)-α-[(S)-1-aminoéthyl- (-)-morphinan-3-ol → Norlevorphanol 1] alcool benzylique → Cathine (-)-N-(2,2-diphenyl-3- (+)-(S)-α-[(S)-1-aminoetil] methyl-4-morpholino- alcohol bencílico → Cathine butyryl)-pyrrolidin → Levomoramide (+)-[Méthyl-2 oxo-4 (-)-N,N-diméthyl diphényl- diphényl-3,3 (pyrrolidinyl- 1,2 ethylamine → Lefetamine 1) butyl-4]-4 morpholine → Dextromoramide (-)-N,N-dimethyl-1,2- (+)-1-(3-methyl-4- diphenylethylamine → Lefetamine morpholino-2,2- (-)-N,N-dimethylstilbylamine → Lefetamine diphenylbutyryl) → Dextromoramide (-)-N,N-dimethyl-α- pyrrolidine phenylbenzenethanamin → Lefetamine (+)-1-(3-methyl-4- (-)-N,N-dimetil-1,2- morpholino-2,2-diphenyl- → Dextromoramide difeniletilamina → Lefetamine butyryl)pyrrolidine (-)-N,α-dimethyl (+)-1-(β-methyl-γ- phenethylamine → Levometamfetamine morpholino-α,α- diphenylbutyryl)- (-)-N,α-dimetilfenetilamina → Levometamfetamine pyrrolidine → Dextromoramide (-)-phényl-1 amino-2 (+)-1,2-diphenyl-2- → propane Levamfetamine propionoxy-3-methyl-4- (-)-phenyl-methyl-morpholin → Phenmetrazine dimethylaminobutane → Dextropropoxyphene (-)-trans-delta-9- (+)-1-[3-methyl-4-(4- tetrahydrocannabinol → Dronabinol morpholinyl)-1-oxo-2,2- (-)-trans-Δ9- diphenylbutyl]pyrrolidine → Dextromoramide tetrahidrocannabinol → Dronabinol (+)-1-phenyl-2-methyl (-)-trans-Δ9- aminopropan → Metamfetamine tetrahydrocannabinol → Dronabinol (+)-2,2-diphenyl-3-methyl-4- (-)-α-(3-hydroxy-17- morpholinobutyryl morphinanyl)acetophenon → Levophenacyl-morphan pyrrolidine → Dextromoramide (-)-α-aminopropiofenona → Cathinone (+)-2-amino-1-fenilpropano → Dexamfetamine (-)-α-aminopropiophenone → Cathinone (+)-2-amino-1-phenyl (-)-α-aminopropiophénone → Cathinone propan-1-ol → Cathine (+)-2-amino-1-phenyl (-)-α-methylphenethylamine → Levamfetamine 8 propane → Dexamfetamine (-)-Δ -trans- tetrahydrocannabinol → Tetrahydro-cannabinol (+)-2-aminopropylbenzene → Dexamfetamine (+)-(1S,2R)-1-benzyl-3- (+)-2-methylamino-1- (dimethylamino)-2- phenylpropane → Metamfetamine methyl-1-phenylpropyl (+)-2-metilamino-1- propionate → Dextropropoxyphene fenilpropano → Metamfetamine (+)-(2S,3S)-3,4-dimethyl-2- (+)-2-phenyl-3,4- phenylmorpholine → Phendimetrazine dimethyltetrahydro-1,4- (+)-(2S,3S)-3,4-dimetil-2- oxazin → Phendimetrazine fenilmorfolina → Phendimetrazine (+)-3,4-dimethyl-2- (+)-(2S,3S)-diméthyl-3,4 phenylmorpholin, -e → Phendimetrazine phényl-2 morpholine → Phendimetrazine 316 (+)-3-methyl-4-morpholino- (+)-méthylamino-2 phényl-1 2,2-diphenyl-(1- propane → Metamfetamine pyrrolidinyl)-butanon → Dextromoramide (+)-N-(2,2-diphenyl-3- (+)-3-methyl-4-morpholino- methyl-4-morpholino- 2,2-diphenyl-1-(pyrrolidin- butyryl)pyrrolidin → Dextromoramide 1-yl)-butan-1-on → Dextromoramide (+)-N,N-diethyllysergamide → (+)-Lysergide (+)-3-metil-2,2-difenil-4- (+)-N,N-diéthyllysergamide → (+)-Lysergide morfolino-butiril (+)-N,N-dietilisergamida → (+)-Lysergide pirrolidina → Dextromoramide (+)-3β-benzoyloxytropan-2α- (+)-N,α-dimethylbenzen → Metamfetamine carbonsäuremethylester → d-cocaine ethanamin, -e (+)-3β-benzoyloxytropane- (+)-N,α-dimethyl-N-(phenyl → Benzfetamine 2α-carboxylic acid methyl methyl)benzeneethamine ester → d-cocaine (+)-N,α-dimethyl → Metamfetamine (+)-4-(2-methyl-4-oxo-3,3- phenethylamin, -e diphenyl-4-pyrrolidin-1- (+)-N-benzyl-N,α-dimethyl → ylbutyl)morpholine → Dextromoramide phenethylamin, -e Benzfetamine (+)-4-(dimethylamino)-3- (+)-N-benzyl-N,α-dimethyl → methyl-1,2-diphenyl-2- phenethylamine Benzfetamine butanol propionate → Dextropropoxyphene hydrochloride hydrochloride (+)-4,4-diphenyl-6- (+)-N-ethylamphetamine → Etilamfetamine piperidinoheptan-3-one → Dipipanone (+)-N-méthyl phényl-1 hydrochloride hydrochloride propanamine-2 → Metamfetamine (+)-4-[2-methyl-4-oxo-3,3- (+)-norpseudoefedrina → Cathine diphenyl-4-(1- (+)-norpseudoephedrin, -e → Cathine pyrrolidinyl)butyl] (+)-norpseudoéphedrine → Cathine morpholine → Dextromoramide (+)-norpseudoephedrin (+)-4-[2-methyl-4-oxo-3,3- hydrochlorid → Cathine hydrochloride diphenyl-4-(1- (+)-phényl-1 propanamine-2 → pyrrolidinyl)butyl] Dexamfetamine morpholine bitartrate → Dextromoramide tartrate (+)-phenylisopropylmine → Dexamfetamine (+)-4-[2-metil-4-oxo-3,3- (+)-propoxyphene → Dextropropoxyphene difenil-4-(1- (+)-threo-α-(1-aminoethyl) pirrolidinil)butil] benzyl alcohol → Cathine morfolina → Dextromoramide (+)-α-4-dimethylamino-3- (+)-4-dimethylamino-1,2- methyl-1,2-diphenylbut-2- diphenyl-3-methyl-2- yl propionate → Dextropropoxyphene propionyloxybutane → Dextropropoxyphene (+)-α-methylbenzene (+)-4-dimethylamino-3- ethanamine → Dexamfetamine methyl-1,2-diphenyl-2- (+)-α-methylbenzenethamin → Dexamfetamine → Dextropropoxyphene propionyloxybutan (+)-α-methylphenäthylamin → Dexamfetamine (+)-4-dimethylamino-3- (+)-α-methylphenethylamine
Load more

Recommended publications
  • Minnesota Statutes 1979 Supplement
    MINNESOTA STATUTES 1979 SUPPLEMENT 152.01 PROHIBITED DRUGS CHAPTER 152. PROHIBITED DRUGS Sec. 152.01 Definitions. 152.02 Schedules of controlled substances; admin­ istration of chapter. 152.01 Definitions. [For text of subds 1 to 8, see M.S.1978] Subd. 9. Marijuana. "Marijuana" means all parts of the plant of any species of the genus Cannabis, including all agronomical varieties, whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin, but shall not include the mature stalks of such plant, fiber from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mix­ ture, or preparation of such mature stalks, except the resin extracted therefrom, fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination. [For text of subds 10 to 17, see M.S.1978] [ 1979 c 157 s 1 ] 152.02 Schedules of controlled substances; administration of chapter. [For text of subd 1, see M.S.1978) Subd. 2. The following items are listed in Schedule I: (1) Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the exis­ tence of such isomers, esters, ethers and salts is possible within the specific chemical des­ ignation: Acetylmethadol; Allylprodine; Alphacetylmethadol; Alphameprodine; Alpham- ethadol; Benzethidine; Betacetylmethadol; Betameprodine; Betamethadol; Betaprodine; Clonitazene; Dextromoramide; Dextrorphan; Diampromide; Diethyliambutene; Dime- noxadol; Dimepheptanol; Dimethyliambutene; Dioxaphetyl butyrate; Dipipanone; Ethylmethylthiambutene; Etonitazene; Etoxeridine; Furethidine; Hydroxypethidine; Ke- tobemidone; Levomoramide; Levophenacylmorphan; Morpheridine; Noracymethadol; Norlevorphanol; Normethadone; Norpipanone; Phenadoxone; Phenampromide; Pheno- morphan; Phenoperidine; Piritramide; Proheptazine; Properidine; Racemoramide; Tri­ meperidine.
    [Show full text]
  • Screening/Spot Test of Narcotics
    Indian Journal of Forensic and Community Medicine 2020;7(4):160–165 Content available at: https://www.ipinnovative.com/open-access-journals Indian Journal of Forensic and Community Medicine Journal homepage: https://www.ipinnovative.com/journals/IJFCM Review Article Screening/spot test of narcotics A K Jaiswal1,*, Kamna Sharma2, Rohit Kanojia3, Sally Lukose4 1Dept. of Forensic Medicine & Toxicology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India 2Galgotias University, Greater Noida, Uttar Pradesh, India 3Dept. of Chemistry, University of Delhi, New Delhi, India 4CTM-IRTE, Faridabad, Haryana, India ARTICLEINFO ABSTRACT Article history: Narcotics are the substances used to treat moderate to severe pain. They could be natural like opiates such Received 25-11-2020 as morphine, codeine etc., synthetic like fentanyl, methadone etc., and semi-synthetic like oxycodone, Accepted 02-12-2020 hydrocodone etc. These drugs act as pain relievers, induces the state of stupor or sleep, and increase Available online 08-01-2021 the physical dependence on them. In forensic autopsy case, the forensic pathologist may require a complete toxicological investigation for different poisons including stimulants. In India, Forensic Science Laboratories run by Government under the Home ministry usually carry out this. The samples must be Keywords: analysed by the forensic toxicologist/chemists/scientist. This article deals with the screening/spot test for Narcotics narcotics. It attempts to simplify the standard procedures in a step-wise manner, which can be of handy Screening reference for the forensic toxicologist. Spot test Drugs © This is an open access article distributed under the terms of the Creative Commons Attribution Opioids etc License (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
    [Show full text]
  • Federal Register/Vol. 85, No. 36/Monday, February 24, 2020
    10466 Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices Controlled substance Drug code Schedule Alphamethadol ................................................................................................................................................................. 9605 I Benzethidine .................................................................................................................................................................... 9606 I Betacetylmethadol ........................................................................................................................................................... 9607 I Clonitazene ...................................................................................................................................................................... 9612 I Diampromide ................................................................................................................................................................... 9615 I Diethylthiambutene .......................................................................................................................................................... 9616 I Dimethylthiambutene ....................................................................................................................................................... 9619 I Ketobemidone .................................................................................................................................................................
    [Show full text]
  • 2020 Kansas Statutes
    2020 Kansas Statutes 65-4105. Substances included in schedule I. (a) The controlled substances listed in this section are included in schedule I and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it. (b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation: (1) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide) 9821 (2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide) 9815 (3) Acetylmethadol 9601 (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; acryloylfentanyl) 9811 (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) 9551 (6) Allylprodine 9602 (7) Alphacetylmethadol 9603(except levo-alphacetylmethadol also known as levo- alpha-acetylmethadol, levomethadyl acetate or LAAM) (8) Alphameprodine 9604 (9) Alphamethadol 9605 (10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) 9814 (11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N- phenylpropanamide) 9832 (12) Benzethidine 9606 (13) Betacetylmethadol 9607 (14) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N- phenylpropanamide) 9830 (15) Beta-hydroxy-3-methylfentanyl (other
    [Show full text]
  • A Bill to Repeal Criminal Drug Laws: Replacing Prohibition with Regulation Joseph L
    Hofstra Law Review Volume 18 | Issue 3 Article 10 1990 A Bill to Repeal Criminal Drug Laws: Replacing Prohibition with Regulation Joseph L. Galiber Follow this and additional works at: http://scholarlycommons.law.hofstra.edu/hlr Part of the Law Commons Recommended Citation Galiber, Joseph L. (1990) "A Bill to Repeal Criminal Drug Laws: Replacing Prohibition with Regulation," Hofstra Law Review: Vol. 18: Iss. 3, Article 10. Available at: http://scholarlycommons.law.hofstra.edu/hlr/vol18/iss3/10 This document is brought to you for free and open access by Scholarly Commons at Hofstra Law. It has been accepted for inclusion in Hofstra Law Review by an authorized administrator of Scholarly Commons at Hofstra Law. For more information, please contact [email protected]. Galiber: A Bill to Repeal Criminal Drug Laws: Replacing Prohibition with R A BILL TO REPEAL CRIMINAL DRUG LAWS: REPLACING PROHIBITION WITH REGULATION Joseph L. Galiber* Conventional wisdom obliges elected officials to beat the narcodrums loudly and incessantly, and to demand increasingly harsh criminal penalties for the sale and use of illegal drugs.' It is reasonable to wonder why I, a senator, would dare submit a bill2 to the New York State Legislature which would regulate all drugs cur- rently proscribed as illegal in precisely the same manner as alcohol.3 The short answer is that the use of the criminal law to control drug use has not, and never will, have anything more than a costly and marginal impact on drug consumption.4 Despite all the public hyperventilation, drug consumption remains a private, consensual * New York State Senator; B.A.
    [Show full text]
  • CONTROLLED SUBSTANCE, DRUG, DEVICE and COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun
    CONTROLLED SUBSTANCE, DRUG, DEVICE AND COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun. 23, 2011, P.L. 36, No. 7 Cl. 35 Session of 2011 No. 2011-7 SB 1006 AN ACT Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for Schedule I controlled substances. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Section 4(1) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, amended November 24, 1999 (P.L.894, No.55), is amended to read: Section 4. Schedules of Controlled Substances.--The following schedules include the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. (1) Schedule I--In determining that a substance comes within this schedule, the secretary shall find: a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. The following controlled substances are included in this schedule: (i) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation: 1.
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • Report on a Novel Emerging Class of Highly Potent Benzimidazole NPS Opioids: Chemical and in Vitro Functional Characterization of Isotonitazene
    Received: 29 August 2019 Revised: 12 November 2019 Accepted: 13 November 2019 DOI: 10.1002/dta.2738 RESEARCH ARTICLE Report on a novel emerging class of highly potent benzimidazole NPS opioids: Chemical and in vitro functional characterization of isotonitazene Peter Blanckaert1† | Annelies Cannaert2† | Katleen Van Uytfanghe2 | Fabian Hulpia3 | Eric Deconinck4 | Serge Van Calenbergh3 | Christophe Stove2 1Scientific Direction Epidemiology and Public Health, Section Lifestyle and Chronic Diseases, Abstract Belgian Early Warning System Drugs This paper reports on the identification and full chemical characterization of (BEWSD), Sciensano, Brussels, Belgium isotonitazene (N,N-diethyl-2-[5-nitro-2-({4-[(propan-2-yl)oxy]phenyl}methyl)-1H-ben- 2Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical zimidazol-1-yl]ethan-1-amine), a potent NPS opioid and the first member of the Sciences, Ghent University, Ghent, Belgium benzimidazole class of compounds to be available on online markets. Interestingly, 3Laboratory for Medicinal Chemistry, Department of Pharmaceutics, Faculty of this compound was sold under the name etonitazene, a structural analog. Identifica- Pharmaceutical Sciences, Ghent University, tion of isotonitazene was performed by gas chromatography mass spectrometry Ghent, Belgium (GC–MS) and liquid chromatography time-of-flight mass spectrometry (LC-QTOF- 4Scientific Direction Chemical and Physical Health Risks, Service of Medicines and Health MS), the latter identifying an exact-mass m/z value of 411.2398. All chromatographic Products, Sciensano, Brussels, Belgium data indicated the presence of a single, highly pure compound. Confirmation of the 1 13 Correspondence specific benzimidazole regio-isomer was performed using H and C NMR spectros- copy, after which the chemical characterization was finalized by recording Fourier- Christophe Stove, Laboratory of Toxicology, Department of Bioanalysis, Faculty of transform (FT-IR) spectra.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub
    US 2004.0024006A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0024006 A1 Simon (43) Pub. Date: Feb. 5, 2004 (54) OPIOID PHARMACEUTICAL May 30, 1997, now abandoned, and which is a COMPOSITIONS continuation-in-part of application No. 08/643,775, filed on May 6, 1996, now abandoned. (76) Inventor: David Lew Simon, Mansfield Center, CT (US) Publication Classification Correspondence Address: (51) Int. Cl. ................................................ A61K 31/485 David L. Simon (52) U.S. Cl. .............................................................. 514/282 P.O. Box 618 100 Cemetery Road (57) ABSTRACT Mansfield Center, CT 06250 (US) The invention is directed in part to dosage forms comprising a combination of an analgesically effective amount of an (21) Appl. No.: 10/628,089 opioid agonist analgesic and a neutral receptor binding agent or a partial mu-opioid agonist, the neutral receptor binding (22) Filed: Jul. 25, 2003 agent or partial mu-opioid agonist being included in a ratio Related U.S. Application Data to the opioid agonist analgesic to provide a combination product which is analgesically effective when the combina (63) Continuation-in-part of application No. 10/306,657, tion is administered as prescribed, but which is leSS analge filed on Nov. 27, 2002, which is a continuation-in-part Sically effective or less rewarding when administered in of application No. 09/922,873, filed on Aug. 6, 2001, excess of prescription. Preferably, the combination product now Pat. No. 6,569,866, which is a continuation-in affects an opioid dependent individual differently from an part of application No. 09/152,834, filed on Sep.
    [Show full text]
  • Federal Register / Vol. 62, No. 89 / Thursday, May 8, 1997 / Notices
    Federal Register / Vol. 62, No. 89 / Thursday, May 8, 1997 / Notices 25211 factors in Title 21, United States Code, Sched- Sched- Section 823(a) and determined that the Drug ule Drug ule registration of Pharmacia & Upjohn Company to manufacture 2,5- Betamethadol (9609) ....................... I Morphine (9300) .............................. II Dimethoxyamphetamine is consistent Norlevorphanol (9634) .................... I Para-Fluorofentanyl (9812) ............. I The firm plans to manufacture small with the public interest at this time. Alpha-methylfentanyl (9814) ........... I Therefore, pursuant to 21 U.S.C. § 823 Acetyl-alpha-methylfentanyl (9815) I quantities of the listed controlled and 28 CFR 0.100 and 0.104, the Acting Beta-hydroxyfentanyl (9830) ........... I substances for incorporation in drug of Deputy Assistant Administrator, Office Beta-hydroxy-3-methylfentanyl I abuse detection kits. of Diversion Control, hereby orders that (9831). Any other such applicant and any the application submitted by the above Alpha-Methylthiofentanyl (9832) ..... I person who is presently registered with firm for registration as a bulk 3-Methylthiofentanyl (9833) ............. I DEA to manufacture such substances Thiofentanyl (9835) ......................... I manufacturer of the basic class of Phenmetrazine (1631) ..................... II may file comments or objections to the controlled substance listed above is Glutethimide (2550) ......................... II issuance of the above application. granted. Cocaine (9041) ................................ II Any such comments or objections Dated: March 31, 1997. Codeine (9050) ............................... II may be addressed, in quintuplicate, to Terrance W. Woodworth, Levomethorphan (9210) .................. II the Acting Deputy Assistant Levorphanol (9220) ......................... II Acting Deputy Assistant Administrator, Office Administrator, Office of Diversion of Diversion Control, Drug Enforcement Control, Drug Enforcement Administration. No comments or objections have been received.
    [Show full text]
  • Drugs of Abuseon September Archived 13-10048 No
    U.S. DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION WWW.DEA.GOV 9, 2014 on September archived 13-10048 No. v. Stewart, in U.S. cited Drugs of2011 Abuse EDITION A DEA RESOURCE GUIDE V. Narcotics WHAT ARE NARCOTICS? Also known as “opioids,” the term "narcotic" comes from the Greek word for “stupor” and originally referred to a variety of substances that dulled the senses and relieved pain. Though some people still refer to all drugs as “narcot- ics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, morphine, methadone and fentanyl. WHAT IS THEIR ORIGIN? The poppy papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine cabinets, pharmacies, nursing 2014 homes, hospitals, hospices, doctors, and the Internet. 9, on September archived 13-10048 No. v. Stewart, in U.S. cited What are common street names? Street names for various narcotics/opioids include: ➔ Hillbilly Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton, Sippin Syrup What are their forms? Narcotics/opioids come in various forms including: ➔ T ablets, capsules, skin patches, powder, chunks in varying colors (from white to shades of brown and black), liquid form for oral use and injection, syrups, suppositories, lollipops How are they abused? ➔ Narcotics/opioids can be swallowed, smoked, sniffed, or injected.
    [Show full text]
  • Guidelines for Ensuring Patient Access To, and Safe Management Of, Controlled Medicines Notice
    African Palliative Care Association Guidelines for Ensuring Patient Access to, and Safe Management of, Controlled Medicines Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. APCA and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of this publication. However, in view of the possibility of human error or changes in sciences, neither APCA nor the publisher nor any other party who have been involved in the preparation or publication of this work warrants that the information contained in this publication is complete and correct and they disclaim all responsibility for any errors or omission or for the results obtained from use of the information contained herein. African Palliative Care Association Foreword The 59th Session of the World Health conventions. Several countries make the Assembly of the UN adopted resolution importation, storage, distribution and 58.22, thereby recognising the dispensing of controlled medicines more importance of improving pain relief restrictive than is needed. Additionally, using opioid analgesics and calling on it is a requirement for countries to member states to remove barriers to provide detailed annual estimates and their medical use and availability. reports for narcotic substances to the International Narcotic Control Board to While advances have been made pursuing procure or produce controlled medicines. this agenda in Africa (e.g. legalisation of However, formulating reliable estimates oral morphine prescription rights for nurses is often a barrier to accessing controlled and clinical officers in Uganda, approval medicines, while the procurement of access to morphine for hospices of opioids is subject to complex and in Zambia, and advocacy progress in lengthy exportation and importation Malawi and Kenya), challenges remain.
    [Show full text]